key: cord-0881184-0dp28rsd authors: Abate, Semagn Mekonnen; Ahmed Ali, Siraj; Mantfardo, Bahiru; Basu, Bivash title: Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis date: 2020-07-10 journal: PLoS One DOI: 10.1371/journal.pone.0235653 sha: cb2d17cb233270a63239e7763390a745ac08c0e9 doc_id: 881184 cord_uid: 0dp28rsd BACKGROUND: The rate of ICU admission among patients with coronavirus varied from 3% to 100% and the mortality was as high as 86% of admitted patients. The objective of the systematic review was to investigate the rate of ICU admission, mortality, morbidity, and complications among patients with coronavirus. METHODS: A comprehensive strategy was conducted in PubMed/Medline; Science direct and LILACS from December 2002 to May 2020 without language restriction. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. All observational studies reporting rate of ICU admission, the prevalence of mortality and its determinants among ICU admitted patients with coronavirus were included and the rest were excluded RESULT: A total of 646 articles were identified from different databases and 50 articles were selected for evaluation. Thirty-seven Articles with 24983 participants were included. The rate of ICU admission was 32% (95% CI: 26 to 38, 37 studies and 32, 741 participants). The Meta-Analysis revealed that the pooled prevalence of mortality in patients with coronavirus disease in ICU was 39% (95% CI: 34 to 43, 37 studies and 24, 983 participants). CONCLUSION: The Meta-Analysis revealed that approximately one-third of patients admitted to ICU with severe Coronavirus disease and more than thirty percent of patients admitted to ICU with a severe form of COVID-19 for better care died which warns the health care stakeholders to give attention to intensive care patients. REGISTRATION: This Systematic review and Meta-Analysis was registered in Prospero international prospective register of systemic reviews (CRD42020177095) on April 9/2020. cardiac disease), history of smoking, and history of substance use, male gender and age greater than 60 years were more likely to die or develop undesirable outcomes [25, [28] [29] [30] [31] [32] [33] [34] [35] . The outcomes of patients with coronavirus infection are very variable. Studies also showed that the rate of ICU admission among coronavirus infected patients was higher which ranged from 3% to 100% of confirmed cases [14, 17, 19, 26, 28, [36] [37] [38] [39] . Studies also showed that the prevalence of mortality among intensive care patients with coronavirus infection was very high which ranged from 6% to 86% of admitted patients [14, 17, 19, 26, 28, [36] [37] [38] [39] . The global rate of ICU admission, the prevalence of mortality, comorbidities, complication, number of cases demanding mechanical ventilator, length of stay and independent risk factors for ICU mortality are very important variables to be determined to reduce patient mortality and morbidity through varies mitigating strategies including but not limited to increasing number of ICU beds, mechanical ventilator, skilled professionals, integrated monitors and reducing possible risk factors. Therefore, the objectives of this systematic review and Meta-Analysis was to provide global evidence on the rates of ICU admission, the prevalence of mortality, comorbidity, complications, and independent risk factors of mortality among patients with COVID-19 admitted in ICU. The systematic review and meta-analysis were conducted based on the Preferred Reporting Items for Systematic and Meta-analysis (PRISMA) protocols [40] . This Systematic Review and Meta-Analysis was registered in Prospero international prospective register of systemic reviews (CRD42020177095) on April 9/2020. 2.2.1. Inclusion criteria. All observational (case series, cross-sectional, cohort, and casecontrol) studies reporting rate of ICU admission, the prevalence of mortality, morbidity, complication, and its determinants among ICU admitted patients with coronavirus (SARS-COV, MERS and SARS-COV 2) were included. Studies that didn't report the rate of ICU admission, the prevalence of ICU mortality, and risk factors among patients with coronavirus were excluded. Besides, Randomized controlled trials, case-control studies, Systemic reviews, and Case reports were excluded. The search strategy was intended to explore all available published and unpublished studies among Coronaviruses infected patients admitted to ICU from December 2002 to May 2020 without language restrictions. A comprehensive initial search was employed in PubMed/Medline, Science direct, and LILACS followed by an analysis of the text words contained in Title/ Abstract and indexed terms. A second search was undertaken by combining free text words and indexed terms with Boolean operators. The third search was conducted with the reference lists of all identified reports and articles for additional studies. Finally, an additional and grey literature search was conducted on Google scholars. The PubMed/Medline database was searched with the following terms: The data from each study were extracted with two independent authors with a customized format. The disagreements between the two independent authors were resolved by the other two authors. The extracted data included: Author names, country, date of publication, sample size, the rates of ICU admission, mortality, types of Coronavirus, types of comorbidity, complications, and risk factors. Finally, the data were then imported for analysis in R software version 3.6.1 and STATA 14. Articles identified for retrieval were assessed by two independent Authors for methodological quality before inclusion in the review using a standardized critical appraisal Tool adapted from the Joanna Briggs Institute [45, 46] (S1 Table) . The disagreements between the Authors appraising the articles were resolved through discussion with the other Two Authors. Articles with average scores greater than fifty percent were included for data extraction. Data analysis was carried out in R statistical software version 3.6.1 and STATA 14. The pooled rates of ICU admission and prevalence of mortality, comorbidity, complication among corona virus-infected patients were determined with a random effect model as there was substantial heterogeneity between the included studies. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I 2 test, and the p-values. Subgroup analysis was conducted by Country, type of coronavirus, types of comorbidity, and complications. Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests, and Trim and fill method. Furthermore, moderator analysis was carried out to identify the independent predictors of ICU mortality among corona cases. The results were presented based on the Preferred Reporting Items for Systemic Reviews and Meta-Analysis (PRISMA) [40] . Ethical clearance and approval were obtained from the ethical review board of the College of Health Science and Medicine. A total of 646 articles were identified from different databases with an initial search. Fifty articles were selected for evaluation after the successive screening. Thirty-seven Articles with 24983 participants were included in the systematic review and Meta-Analysis while thirteen studies were excluded with reasons (Fig 1) . Thirty-seven studies conducted on Coronavirus reporting rates of ICU admission and patient outcomes with 24983 participants were included (Table 1) . Thirteen studies were excluded with reasons (S1 Table) . The methodological quality of included studies was moderate to high quality as depicted with the Joanna Briggs Appraisal tool for observational studies (S2 Table) . Twenty-six of the included studies were conducted on a newly emerged Coronavirus (SARS-CoV-2), COVID-19. Seven studies were conducted during and after the aftermath of The included studies were conducted in different regions of the world. Sixteen studies were conducted in China, seven studies in Saudi Arabia, five studies in the United States of America, three studies in Italy, two studies in Singapore, one study in Holland, the United Kingdom, and France. All of the included studies reported rates of ICU admission and outcomes of patients while staying in ICU. The majority of the included studies reported the presence of comorbidities and complications in ICU such as death, acute respiratory distress syndrome, renal failure, shock, and discharge. 3.3.1. Rate of ICU admission. Thirty-seven studies reported ICU admission were included for Meta-analysis. The number of ICU admission was taken for estimation of pooled prevalence of mortality instead of the total sample size because we wanted to know the number of ICU deaths from those Admitted in ICU. However, the rates of ICU admission were estimated with the total sample size. The pooled rate of ICU admission was 32% (95% CI: 26 to 38, 37 studies and 32, 741 participants) (Fig 2) . The finding of the subgroup analysis by types of corona revealed that the rate of ICU admission with SARS-COV, MERS and SARS-COV-2 was 32% (95% CI, 23 to 40), 57% 95% CI, 37 to 76) and 26% 95% CI, 20 to 33) respectively (Fig 3) . The Meta-Analysis showed that the prevalence of mortality among ICU admitted patients with Coronavirus was 39% (95% CI: 34 to 43, 37 studies and 24, 983 participants) (Fig 4) . The subgroup analysis of the pooled prevalence of mortality among ICU admitted patients with Coronavirus showed that mortality was higher in Saudi Arabia with the Middle East respiratory syndrome 61%(95% CI: 44 to 78) while the prevalence of ICU mortality among patients with the severe acute respiratory syndrome (SARS-CoV-2) was 31% (95% CI: 26to 36) (Fig 5) . The subgroup analysis by country revealed that ICU mortality with COVID-19 was 31% (95% CI: 44 to 78, 25 studies, 24677 participants) where the highest was in China 42% (95% CI: 23 to 61, 13 studies, 1480 participants) followed by USA 36% (95% CI: 18 to 53, 5 studies, 992 participants) (S1 Fig). The prevalence of comorbidity among ICU patients with coronavirus was 66% (95% confidence interval (CI): 47 to 85, 12 studies, and 2614 participants) (Fig 6) . The Meta-Analysis also revealed that the prevalence of comorbidity among COVID-19 Patients admitted in ICU was 59% (95% confidence interval (CI): 39 to 79, 10 studies and 896 participants) (S2 Fig). The subgroup analysis by the types of comorbidity showed that cardiovascular diseases were the most prevalent 55% (95% confidence interval (CI): 46 to 64) followed by hypertension and Diabetes Mellitus, 38% (95% confidence interval (CI): 26 to 55) and 31% (95% confidence interval (CI): 20 42) respectively (Fig 7) . The Meta-Analysis showed that the prevalence of complications among ICU admitted patients with coronavirus was 68% (95% confidence interval (CI): 33 to 104) (Fig 8) . The subgroup analysis by types of complication showed that ARDS was the most prevalent complication, 54% (95% confidence interval (CI): 26 to 82) followed by infection and sepsis, 47% (95% confidence interval (CI): 29 to 65) and 37% (95% confidence interval (CI): 26 to 49) respectively (S3 Fig). The prevalence of mortality among patients with Coronavirus was greatly affected by several factors including the presence of co-morbidities, history of smoking, history of substance use, male gender, older age groups, ICU admission, nosocomial infection, and others. The Sensitivity analysis was conducted to identify the most influential study on the pooled summary effect and we didn't find significant influencing the summary effect. Publication bias was investigated with funnel plot asymmetry and egger's regression and Begg's rank correlation were run to investigate publication bias objectively. The funnel plot didn't show significant publication bias. Neither egger's regression nor Begg's rank correlation showed significant publication bias (P-value < 0.1464) (Fig 9) . The Meta-Analysis revealed that more than one-third of patients with coronavirus infection were admitted to ICU globally. The subgroup analysis showed that the rate of ICU admission was very high in patients with the Middle East respiratory syndrome (MERS-CoV), 57% (95% CI: 37to 76) as compared to severe acute respiratory syndrome (SARS-CoV-2 and SARS-CoV), 26% (95% CI: 20 to 33) and 32% (95% CI: 23 to 40) respectively. Currently, the total confirmed cases and the death of patients with the SARS-CoV-2 virus is unpredictably high as compared to the previous two outbreaks [13-15, 19, 20, 63, 64, 66-68] . The lower rate of ICU admission in patients with COVID-19 in this systematic review and Meta-Analysis might be due to a small number of studies assessing rates of admission compared to the number of cases and also the majority of studies were case series with small sample size. This systematic review and Meta-Analysis revealed that the prevalence of mortality among Coronavirus confirmed cases admitted in ICU were, 39% (95% CI: 34 to 43). This finding is interpreted as there is one mortality for every three cases of admission. This finding is in line with individual studies conducted among Coronavirus confirmed cases since the first outbreak in 2002, China [13-15, 19, 20, 63, 64, 66-68] . The possible explanation for a high number of deaths in ICU may be explained in terms of a limited number of mechanical ventilators, adequate laboratory investigation, integrated patient monitors, presence of co-morbidities, hospital-acquired infections, and some others. The subgroup analysis showed that the prevalence of mortality among COVID-19 patients admitted in ICU was very higher, 31% (95% CI: 26 to 36). But, it is relatively low as compared to MERS-CoV and SARS-CoV, 61% (95% CI: 44 to 78), and 49% (95% CI: 41 to 57) respectively. The possible explanation for the lower prevalence of mortality among COVID-19 patients might be due to better ICU supportive management, skilled ICU professionals, integrated patient monitors, and lessons from previous outbreaks in handling ICU cases. The pooled prevalence of comorbidity among patients with coronavirus was as high as sixty percent. The subgroup analysis revealed that the prevalence of comorbidity among COVID-19 patients was 59% (95% confidence interval (CI): 39 to 79) which is consistent with findings of subgroup analysis of SARS-COV, MERS-COV, and individual included studies. The regression analysis revealed that presences of comorbidity, male gender, age greater than 50 years, and ARDS were independent predictors of mortality among patients admitted in ICU with coronaviruses. The systematic review and meta-analysis included plenty of studies with adequate sample size. The methodological quality of included studies was moderate to high quality as depicted with Joanna Briggs Institute assessment tool for meta-analysis of observational studies. However, substantial heterogeneity associated with dissimilarities of included studies in sample size, design, and location could affect the allover quality of evidence. The review incorporated plenty of studies with a large number of participants but the majority of studies included in this review didn't report data on comorbidity and risk factors to investigate the independent predictors. Besides, there were a limited number of studies in some countries and it would be difficult to provide conclusive evidence with results pooled from fewer studies. Body of evidence revealed that rate of ICU admission; the prevalence of mortality; morbidity and complications were very high among patients with COVID-1. These could be a huge impact particularly for low and middle-income countries with a limited number of ICU beds, mechanical ventilator, integrated patient monitor, skilled professionals combined with malnutrition, and communicable disease. Therefore, a mitigating strategy is required by different stakeholders to combat the catastrophic impacts of COVID-19 pandemic through creating awareness about preventive measures, implementing ICU protocols for supportive management, management of comorbidities, and prevention of complications. The meta-analysis revealed that the prevalence of mortality among COVD-19 in ICU was very high and the major independent predictors of mortality were identified. However, the included studies were too heterogeneous, and cross-sectional studies also don't show a temporal relationship between mortality and its determinants. Therefore, further observational and randomized controlled trials are in demand for a specific group of patients by stratifying the possible independent predictors. The systematic review and Meta-Analysis revealed that approximately one-third of patients admitted to ICU with severe Coronavirus disease. The systematic review also showed that more than thirty percent of patients admitted in ICU with a severe form of COVID-19 for better care died which warns the health care stakeholders to give attention to intensive care patients admitted with COVID-19 through accessing mechanical ventilators, integrated patient monitors, skilled ICU staffs, creation of awareness about infection prevention and more others. Besides, the prevalence of mortality had a strong relation with comorbidity, age, gender, and complication. Human coronavirus-HKU1 infection among adults in Coronaviruses: emerging and re-emerging pathogens in humans and animals Review of bats and SARS. Emerging infectious diseases Coronavirus pathogenesis, and the emerging pathogen severe acute respiratory syndrome coronavirus The SARS-CoV-2 outbreak: what we know Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The Lancet Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi Coronavirus disease 2019 (COVID-19) Situation Report -72 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Short term outcome and risk factors for adverse clinical outcomes in adults with the severe acute respiratory syndrome (SARS) Clinical features and outcomes of the severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome Outcomes and prognostic factors in 267 patients with the severe acute respiratory syndrome in Hong Kong SARS in the intensive care unit The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study. Annals of intensive care Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection Hospital outbreak of Middle East respiratory syndrome coronavirus Coronavirus disease 2019 (COVID-19) Situation Report -52 Coronavirus disease 2019 (COVID-19) Situation Report -141 The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study Critically ill patients with Middle East respiratory syndrome coronavirus infection Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State Clinical characteristics and outcome of ICU admitted MERS corona, virus-infected patients Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine Hospital outbreak of Middle East respiratory syndrome coronavirus Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data. medRxiv Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese medical journal Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. American journal of obstetrics and gynecology Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis COVID-19: a novel coronavirus and a novel challenge for critical care Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State Clinical characteristics of 113 deceased patients with coronavirus disease 2019: a retrospective study Clinical, laboratory, and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese medical journal Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Covid-19 in critically ill patients in the Seattle regioncase series Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States Clinical features and short-term outcomes of 18 patients with coronavirus disease 2019 in the intensive care unit Clinical progression of patients with COVID-19 in Shanghai Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. clinical medicine Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: a prospective observational cohort study Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study Characteristics, treatment, outcomes, and cause of death of invasively ventilated patients with COVID-19 ARDS in Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region Acute respiratory distress syndrome in critically ill patients with the severe acute respiratory syndrome Presentation and outcome of the Middle East respiratory syndrome in Saudi intensive care unit patients A comparative study of clinical presentation and risk factors for adverse outcomes in patients hospitalized with acute respiratory disease due to MERS coronavirus or other causes Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery The authors would like to acknowledge Dilla University for technical support and encouragement to carry out the project.